These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31424701)

  • 21. A retrospective study of 34 catatonic patients: analysis of clinical care and treatment.
    Tuerlings JH; van Waarde JA; Verwey B
    Gen Hosp Psychiatry; 2010; 32(6):631-5. PubMed ID: 21112456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuroleptic malignant syndrome: a life-threatening complication that can be treated effectively].
    Rondeel JM
    Ned Tijdschr Geneeskd; 2007 Jan; 151(2):154; author reply 154-5. PubMed ID: 17315497
    [No Abstract]   [Full Text] [Related]  

  • 23. Catatonia. 2: Diagnosis, management and prognosis.
    Clark T; Rickards H
    Hosp Med; 1999 Nov; 60(11):812-4. PubMed ID: 10707192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report.
    Nolen WA; Zwaan WA
    Acta Psychiatr Scand; 1990 Jul; 82(1):90-2. PubMed ID: 2399829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G; Susman VL
    J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Catatonia and neuroleptic malignant syndrome in a mentally retarded patient].
    Heikkilä J; Raitasuo S; Lauerma H; Mölsä P
    Duodecim; 1992; 108(12):1120-4. PubMed ID: 1366062
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for neuroleptic malignant syndrome.
    Francis A; Chandragiri S; Petrides G
    Am J Psychiatry; 1998 Nov; 155(11):1639-40. PubMed ID: 9812151
    [No Abstract]   [Full Text] [Related]  

  • 28. Lethal catatonia.
    Ljubisavljevic V
    Aust N Z J Psychiatry; 2002 Aug; 36(4):563-4. PubMed ID: 12169165
    [No Abstract]   [Full Text] [Related]  

  • 29. Transient Fever Response After ECT in a Patient with Catatonic Schizophrenia: A Case Report.
    Alp A; Doğan MK; Eroğlu EÖ; Yildiz Mİ; Gürel ŞC; Özer S
    Turk Psikiyatri Derg; 2024; 35(1):78-82. PubMed ID: 38556940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant catatonia in a patient with bipolar disorder, B12 deficiency, and neuroleptic malignant syndrome: one cause or three?
    Lewis AL; Pelic C; Kahn DA
    J Psychiatr Pract; 2009 Sep; 15(5):415-22. PubMed ID: 19820558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB
    Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Litta A; Kansky C; Mauri M; Cassano GB; Fagiolini A; Casamassima F
    J Nerv Ment Dis; 2013 Jan; 201(1):36-42. PubMed ID: 23274293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant catatonia with severe bronchorrhea and its response to electroconvulsive therapy.
    Hayashi H; Aoshima T; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):310-1. PubMed ID: 16378669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic difficulties and efficacy of electroconvulsive therapy in the treatment of lethal catatonia].
    Turczyński J
    Psychiatr Pol; 1993; 27(5):535-43. PubMed ID: 7902992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptic malignant syndrome and catatonia. A report of three cases.
    Raja M; Altavista MC; Cavallari S; Lubich L
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):299-303. PubMed ID: 7913834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evaluation and management of patients with neuroleptic malignant syndrome.
    Bhanushali MJ; Tuite PJ
    Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome and its controversies.
    Margetić B; Aukst-Margetić B
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Catatonia in clinical reality: underdiagnosed and forgotten].
    Adorjan K; Falkai P; Pogarell O
    MMW Fortschr Med; 2019 Dec; 161(Suppl 7):7-11. PubMed ID: 31828672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lethal catatonia.
    Mann SC; Caroff SN; Bleier HR; Welz WK; Kling MA; Hayashida M
    Am J Psychiatry; 1986 Nov; 143(11):1374-81. PubMed ID: 3777225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of neuroleptic malignant syndrome with electroconvulsive therapy.
    Lazarus A
    J Nerv Ment Dis; 1986 Jan; 174(1):47-9. PubMed ID: 3941310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.